Ribaudo H - Search Results

1

Proteinuria and albuminuria among a global primary cardiovascular disease prevention cohort of people with HIV.

Overton ET, Kantor A, Fitch KV, Mosepele M, Aberg JA, Fichtenbaum CJ, McComsey GA, Malvestutto C, Lu MT, Negredo E, Bernardino J, Hickman AB, Douglas PS, Grinspoon SK, Zanni M, Ribaudo H, Wyatt C; REPRIEVE Trial Investigators. Overton ET, et al. Among authors: ribaudo h. AIDS. 2025 Jan 1;39(1):31-39. doi: 10.1097/QAD.0000000000004016. Epub 2024 Sep 13. AIDS. 2025. PMID: 39283736 Clinical Trial.

2

Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.

Lehmann DS, Ribaudo HJ, Daar ES, Gulick RM, Haubrich RH, Robbins GK, de Bakker PI, Haas DW, McLaren PJ. Lehmann DS, et al. Among authors: ribaudo hj. Pharmacogenet Genomics. 2015 Feb;25(2):51-9. doi: 10.1097/FPC.0000000000000106. Pharmacogenet Genomics. 2015. PMID: 25461247 Free PMC article.

3

Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230.

Kumarasamy N, Aga E, Ribaudo HJ, Wallis CL, Katzenstein DA, Stevens WS, Norton MR, Klingman KL, Hosseinipour MC, Crump JA, Supparatpinyo K, Badal-Faesen S, Bartlett JA. Kumarasamy N, et al. Clin Infect Dis. 2015 May 15;60(10):1552-8. doi: 10.1093/cid/civ109. Epub 2015 Feb 18. Clin Infect Dis. 2015. PMID: 25694653 Free PMC article.

4

Change in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals.

Shikuma CM, Ribaudo HJ, Zheng Y, Gulick RM, Meyer WA, Tashima KT, Bastow B, Kuritzkes DR, Glesby MJ; AIDS Clinical Trials Group A5095 Study Team. Shikuma CM, et al. AIDS Res Hum Retroviruses. 2011 May;27(5):461-8. doi: 10.1089/aid.2010.0154. Epub 2010 Nov 23. AIDS Res Hum Retroviruses. 2011. PMID: 20863238 Free PMC article. Clinical Trial.

5

A comparison of three initial antiretroviral AIDS regimens.

Ribaudo HJ, Kuritzkes DR, Gulick RM. Ribaudo HJ, et al. N Engl J Med. 2007 Sep 6;357(10):1056-7. doi: 10.1056/NEJMc070207. N Engl J Med. 2007. PMID: 17804858 Clinical Trial. No abstract available.

6

Substitution of nevirapine because of efavirenz toxicity in AIDS clinical trials group A5095.

Schouten JT, Krambrink A, Ribaudo HJ, Kmack A, Webb N, Shikuma C, Kuritzkes DR, Gulick RM. Schouten JT, et al. Clin Infect Dis. 2010 Mar 1;50(5):787-91. doi: 10.1086/650539. Clin Infect Dis. 2010. PMID: 20121419 Free PMC article. Clinical Trial.

7

Design issues in initial HIV-treatment trials: focus on ACTG A5095.

Ribaudo HJ, Kuritzkes DR, Schackman BR, Acosta EP, Shikuma CM, Gulick RM. Ribaudo HJ, et al. Antivir Ther. 2006;11(6):751-60. Antivir Ther. 2006. PMID: 17310819

8

Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.

Chen JY, Ribaudo HJ, Souda S, Parekh N, Ogwu A, Lockman S, Powis K, Dryden-Peterson S, Creek T, Jimbo W, Madidimalo T, Makhema J, Essex M, Shapiro RL. Chen JY, et al. J Infect Dis. 2012 Dec 1;206(11):1695-705. doi: 10.1093/infdis/jis553. Epub 2012 Oct 12. J Infect Dis. 2012. PMID: 23066160 Free PMC article.

9

Metabolic effects of protease inhibitor-sparing antiretroviral regimens given as initial treatment of HIV-1 Infection (AIDS Clinical Trials Group Study A5095).

Shikuma CM, Yang Y, Glesby MJ, Meyer WA 3rd, Tashima KT, Ribaudo HJ, Webb N, Bastow B, Kuritzkes DR, Gulick RM. Shikuma CM, et al. J Acquir Immune Defic Syndr. 2007 Apr 15;44(5):540-50. doi: 10.1097/QAI.0b013e318031d5a0. J Acquir Immune Defic Syndr. 2007. PMID: 17245230 Clinical Trial.

10

Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects.

Kuritzkes DR, Lalama CM, Ribaudo HJ, Marcial M, Meyer WA 3rd, Shikuma C, Johnson VA, Fiscus SA, D'Aquila RT, Schackman BR, Acosta EP, Gulick RM. Kuritzkes DR, et al. J Infect Dis. 2008 Mar 15;197(6):867-70. doi: 10.1086/528802. J Infect Dis. 2008. PMID: 18269317

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters